Siemens Healthineers Cuts Revenue Outlook on Diagnostics Weakness

By Adria Calatayud

Siemens Healthineers cut its full-year outlook for revenue growth, citing a weak performance in its diagnostics segment, but raised its guidance for adjusted earnings due to U.S. tariff refunds.

The German supplier of medical equipment said Friday that it now expects revenue for the year ending in September to grow by between 3.5% and 4.0% on a comparable basis compared with the year before. It had previously forecast comparable revenue growth of 4.5% to 5%.

However, the benefit of tariff refunds prompted Siemens Healthineers to raise its outlook for full-year adjusted basic earnings per share to between 2.35 and 2.45 euros ($2.71-$2.82), compared with a previous range between 2.20 and 2.30 euros.

For the fiscal third quarter ended June 30, a decline in diagnostics revenue also dragged down the group's top-line, while tariff refunds flattered its bottom line.

Siemens Healthineers reported a quarterly net profit of 669 million euros, up from 552 million euros in the year-earlier period.

Revenue was 5.76 billion euros and grew 2.8% on a comparable basis. Analysts had forecast revenue at 5.805 billion euros and comparable growth at 4.6%, according to consensus estimates provided by the company.

Adjusted earnings before interest and taxes were 1.1 billion euros, up 16% on year, after tariff refunds helped the company increase its margin to 19.1% from 16.8%.

Analysts had forecast the metric at 893 million euros, according to the company-compiled consensus.

Write to Adria Calatayud at adria.calatayud@wsj.com

(END) Dow Jones Newswires

July 31, 2026 01:22 ET (05:22 GMT)